Gene delivery and gene therapy of prostate cancer

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• Current prostate cancer treatments like surgery, radiation, and hormonal therapy are insufficient for advanced or recurrent disease.
• There is a critical need for innovative therapeutic strategies to achieve long-term local control and effective systemic treatment for metastatic prostate cancer.

Purpose of the Study:

• To review and summarize the progress of gene therapy approaches for prostate cancer treatment.
• To highlight the potential of gene therapy for both localized and advanced/metastatic prostate cancer.

Main Methods:

• Exploration of various gene therapy strategies, including cytolytic, immunological, and corrective approaches.
• Review of successful applications in preclinical animal models.
• Assessment of translation into early-phase clinical trials.

Main Results:

• Significant advancements in gene therapy for localized prostate cancer have been demonstrated over the past decade.
• Multiple gene therapy strategies have shown success in preclinical studies.
• Several approaches are progressing into early clinical investigations.

Conclusions:

• Gene therapy represents a promising novel treatment modality for prostate cancer, particularly for advanced and recurrent cases.
• A diverse array of gene delivery systems (viral and non-biological) are available for research and clinical application.
• Further development and clinical translation of gene therapy are crucial for improving patient outcomes in prostate cancer.